Holdings
iShares Neuroscience and Healthcare ETF
As of Jul 31, 2026, iShares Neuroscience and Healthcare ETF reported 66 positions worth US$5.24M. Largest: Dianthus Therapeutics, Inc., Xenon Pharmaceuticals Inc. and Praxis Precision Medicines, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Dianthus Therapeutics, Inc. | 2,739 | US$293K | +741 | Jul 31, 2026 |
| Xenon Pharmaceuticals Inc. | 4,264 | US$267K | −155 | Jul 31, 2026 |
| Praxis Precision Medicines, Inc. | 868 | US$267K | +274 | Jul 31, 2026 |
| Acadia Pharmaceuticals Inc. | 9,949 | US$257K | +1,621 | Jul 31, 2026 |
| Arrowhead Pharmaceuticals, Inc. | 3,016 | US$255K | −87 | Jul 31, 2026 |
| Alkermes Plc | 5,153 | US$252K | −1,293 | Jul 31, 2026 |
| Scholar Rock Holding Corporation | 4,979 | US$235K | +904 | Jul 31, 2026 |
| Biogen Inc. | 1,129 | US$229K | +125 | Jul 31, 2026 |
| Neurocrine Biosciences, Inc. | 1,345 | US$224K | −103 | Jul 31, 2026 |
| Ptc Therapeutics, Inc. | 3,109 | US$211K | +171 | Jul 31, 2026 |